NAS
AMPH icon

Nykredit A/S’s Amphastar Pharmaceuticals AMPH Stock Holding History

Nykredit A/S’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12K Buy
+595
New +$12K ﹤0.01% 1851

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nykredit A/S's AMPH Position: Q2 2026 in Review

Nykredit A/S opened a new position in Amphastar Pharmaceuticals (AMPH) in Q2 2026: 595 shares worth $12K. The stake represents ﹤0.01% of the portfolio and ranks #1851 among its holdings.

154 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Nykredit A/S held 595 shares of Amphastar Pharmaceuticals worth $12K as of Q2 2026.
  • Amphastar Pharmaceuticals was a new Nykredit A/S position in Q2 2026.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Nykredit A/S's portfolio in Q2 2026, its #1851 holding.
  • 154 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.